These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1700335)

  • 1. Why are eye muscles frequently involved in myasthenia gravis?
    Kaminski HJ; Maas E; Spiegel P; Ruff RL
    Neurology; 1990 Nov; 40(11):1663-9. PubMed ID: 1700335
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylcholine receptor epitopes in ocular myasthenia.
    Kaminski HJ
    Ann N Y Acad Sci; 1998 May; 841():309-19. PubMed ID: 9668249
    [No Abstract]   [Full Text] [Related]  

  • 3. Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.
    Sommer N; Melms A; Weller M; Dichgans J
    Doc Ophthalmol; 1993; 84(4):309-33. PubMed ID: 8156854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
    O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 6. Myasthenia gravis: a model disorder of acetylcholine receptors.
    Drachman DB
    Res Publ Assoc Res Nerv Ment Dis; 1987; 65():65-82. PubMed ID: 3330842
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular presentation of myasthenia gravis: A natural history cohort.
    Kamarajah SK; Sadalage G; Palmer J; Carley H; Maddison P; Sivaguru A
    Muscle Nerve; 2018 Apr; 57(4):622-627. PubMed ID: 28881457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular myasthenia gravis and chronic inflammatory polyradiculoneuropathy.
    Weinreb H; Klein J; Kupersmith M
    N Y State J Med; 1986 Aug; 86(8):439-42. PubMed ID: 3463893
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum acetylcholine receptor antibody measurement in myasthenia gravis. Some trials to background radioactivity in radioimmunoassay.
    Buot WL; Goto I; Oda K; Kuroiwa Y
    J Neurol Sci; 1982; 57(1):111-20. PubMed ID: 6185642
    [No Abstract]   [Full Text] [Related]  

  • 10. Is "seronegative" MG explained by autoantibodies to MuSK?
    Vincent AC; McConville J; Newsom-Davis J
    Neurology; 2005 Jan; 64(2):399; author reply 399. PubMed ID: 15668461
    [No Abstract]   [Full Text] [Related]  

  • 11. Myasthenia gravis and the Miller-Fisher variant of Guillain-Barré syndrome.
    Newsom-Davis J
    Curr Opin Neurol; 1997 Feb; 10(1):18-21. PubMed ID: 9099522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG; Sidnev DV; Karganov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of myasthenia gravis.
    Hughes BW; Moro De Casillas ML; Kaminski HJ
    Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis.
    Sen S; Banerjee TK
    J Assoc Physicians India; 1995 Jul; 43(7):487-93. PubMed ID: 8713224
    [No Abstract]   [Full Text] [Related]  

  • 16. Myasthenia gravis, a model of organ-specific autoimmune disease.
    Berrih-Aknin S
    J Autoimmun; 1995 Apr; 8(2):139-43. PubMed ID: 7612144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
    Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in the treatment of MuSK antibody-positive myasthenia gravis.
    Stein B; Bird SJ
    J Clin Neuromuscul Dis; 2011 Mar; 12(3):163-4. PubMed ID: 21321497
    [No Abstract]   [Full Text] [Related]  

  • 19. Saccadic eye movements in myasthenia gravis.
    Metz HS; Scott AB; O'Meara DM
    Arch Ophthalmol; 1972 Jul; 88(1):9-11. PubMed ID: 5049464
    [No Abstract]   [Full Text] [Related]  

  • 20. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
    Wu X; Tüzün E
    Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.